Ornidazole Reduces the Progression of Endometriosis in a Rat Model.

Qin, Xiaoduo; Yang, Haiyan; Qiao, Dan; Liu, Xuantong; Liu, Li-Bing; Liu, Su-Fen; Jia, Zhongzhi

Qin, Xiaoduo; Yang, Haiyan; Qiao, Dan; Liu, Xuantong; Liu, Li-Bing; Liu, Su-Fen; Jia, Zhongzhi.

Afiliación

Qin X; Department of Gynecology, Dalian Medical University, Dalian, China.
Yang H; Department of Gynecology, Dalian Medical University, Dalian, China.
Qiao D; Department of Gynecology, Dalian Medical University, Dalian, China.
Liu X; Department of Gynecology, Changzhou No. 2 People's Hospital, Changzhou, China.
Liu LB; Department of Gynecology, Changzhou No. 2 People's Hospital, Changzhou, China.
Liu SF; Department of Gynecology, Changzhou No. 2 People's Hospital, Changzhou, China.
Jia Z; Department of Interventional Radiology, Changzhou No. 2 People's Hospital, Changzhou, China.

Gynecol Obstet Invest ; 87(5): 316-323, 2022.

Article en En | MEDLINE | ID: mdl-36265450

Asunto(s)

Agua Potable; Endometriosis; Ornidazol; Animales; Femenino; Ratas; Antiinflamatorios/uso terapéutico; Modelos Animales de Enfermedad; Endometriosis/patología; Interleucina-6; Ornidazol/uso terapéutico; Ratas Sprague-Dawley; Factor de Necrosis Tumoral alfa/metabolismo; Factor A de Crecimiento Endotelial Vascular/metabolismo

Palabras clave

Antiangiogenesis; Endometriosis; Inflammation; Ornidazole

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ornidazol / Agua Potable / Endometriosis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Gynecol Obstet Invest Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google